Targets to tackle - The pathophysiology of the disease

Current Drug Targets

Volumn 11, Issue 5, 2010, Pages 521-527

  Schmitz, N ^a   Kraus, V B ^b   Aigner, T ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cartilage; Chondrocytes; Drugs; Joints

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

COST OF ILLNESS; DISABILITY; ENDOCRINE DISEASE; EXERCISE; HEALTH CARE COST; HUMAN; INDUSTRIALIZATION; INJURY; JOINT CAPSULE; JOINT DEGENERATION; JOINT FUNCTION; JOINT PROSTHESIS; METABOLIC DISORDER; OSTEOARTHRITIS; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PHYSIOTHERAPY; QUALITY OF LIFE; REVIEW; SOCIOECONOMICS; SYNOVIUM; TREATMENT INDICATION; WEIGHT BEARING;

BONE MATRIX; CARTILAGE; CHONDROCYTES; COLLAGEN; DRUG DELIVERY SYSTEMS; HUMANS; INFLAMMATION MEDIATORS; JOINT CAPSULE; JOINTS; MODELS, BIOLOGICAL; OSTEOARTHRITIS; SYNOVIAL MEMBRANE;

EID: 77951026170     PISSN: 13894501     EISSN: None     Source Type: Journal    
DOI: 10.2174/138945010791011875     Document Type: Review

References (65)

1. Heinegard DK, Pimentel ER. Cartilage matrix proteins. In: Kuettner K, Schleyerbach R, Peyron JG, Hascall VC (eds.), Articular cartilage and osteoarthritis, 1 ed. New York: Raven Press; 1992: 95-110.
2. Bruckner P, van der Rest M. Structure and function of cartilage collagens. Microscopic Res Technol 1994; 28: 378-384
3. von der Mark K. Structure, biosynthesis and gene regulation of collagens in cartilage and bone. In: Seibel MJ, Robins SP, Bilezikian JP (eds.), Dynamics of bone and cartilage metabolism, 1 ed. San Diego: Academic Press; 1999: 3-29.
4. Mendler M, Eich-Bender SG, Vaughan L, Winterhalter KH, Bruckner P. Cartilage contains mixed fibrils of collagen types II, IX and XI. J Cell Biol 1989; 108: 191-197
5. Wu JJ, Eyre DR. Structural anaylsis of cross-linking domains in cartilage type XI collagen. J Biol Chem 1995; 270: 18865-18870
6. van der Rest M, Mayne R. Type IX collagen proteoglycan from cartilage is covalently cross- linked to type II collagen. J Biol Chem 1988; 263: 1615-1618 (Pubitemid 18052107)
7. Mayne R. Cartilage collagens - What is their function, and are they involved in articular disease? Arthritis Rheum 1989; 32-3: 241-246
8. Roughley PJ, Lee ER. Cartilage proteoglycans: structure and potential functions. Microsc Res Tech 1994; 28: 385-397
9. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965; 19: 739-744
10. Carney SL, Muir H. The structure and function of cartilage proteoglycans. Physiolog Rev 1988; 68: 858-910.
11. Hedlund H, Mengeralli-Widholm S, Heinegard DK, Reinholt FP, Svensson O. Fibromodulin distribution and association with collagen. Matrix Biol 1994; 14: 227-232.
12. Wiberg C, Hedbom E, Khairullina A, et al. Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem 2001; 276: 18947-18952 (Pubitemid 37411216)
13. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995; 96: 2859-2869
14. Handley CJ, McQuillan DJ. Steady-state metabolism in cartilage explants. In: Kuettner K, Ed. Articular cartilage biochemistry, 1 ed. New York: Raven Press; 1986: 163-179
15. Mok SS, Masuda K, Häuselmann HJ, Aydelotte MB, Thonar EJMA. Aggrecan synthesized by mature bovine chondrocytes suspended in alginate. J Biol Chem 1994; 269: 33021-33027
16. Mankin HJ, Dorfman H, Lippiello L, Zarins A. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg 1971; 53-A: 523-537
17. Mankin HJ, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. J Bone Joint Surg 1970; 52-A: 424-434
18. Stabler TV, Byers SS, Zura RD, Kraus VB. Amino acid racemization reveals differential protein turnover in osteoarthritic articular and meniscal cartilages. Arthritis Res Ther 2009; 11.
19. Sivan SS, Wachtel E, Tsitron E, et al. Collagen turnover in normal and degenerate human intervertebral discs as determined by the racemization of aspartic acid. J Biol Chem 2008; 283: 8796-8801
20. Maroudas A. Balance between swelling pressure and collagen tension in normal and degenerate cartilage. Nature 1976; 260: 808-809
21. Bank RA, Krikken M, Beekman B, et al. A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage. Matrix Biol 1997; 16: 233-243 (Pubitemid 27503810)
22. Dodge GR, Poole AR. Immunohistochemical detection and immunohistochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1. J Clin Invest 1989; 83: 647-661
23. Burrage PS, Brinckerhoff CE. Molecular targets in osteoarthritis: Metalloproteinases and their inhibitors. Curr Drug Targets 2007; 8: 293-303. (Pubitemid 46299677)
24. Lippiello L, Hall MD, Mankin HJ. Collagen synthesis in normal and osteoarthrotic human cartilage. J Clin Invest 1977; 59: 593-600. (Pubitemid 8078652)
25. Eyre DR, McDevitt CA, Billingham MEJ, Muir H. Biosynthesis of collagen and other matrix proteins by articular cartilage in experimental osteoarthrosis. Biochem J 1980; 188: 823-837 (Pubitemid 10023631)
26. Mankin HJ, Johnson ME, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. III. Distribution and metabolism of amino sugar-containing macromolecules. J Bone Joint Surg 1981; 63-A-1: 131-139 (Pubitemid 11183716)
27. Aigner T, Stoss H, Weseloh G, Zeiler G, von der Mark K. Activation of collagen type II expression in osteoarthritic and rheumatoid cartilage. Virchows Arch B Cell Pathol Incl Mol Pathol 1992; 62: 337-345 (Pubitemid 23134398)
28. Aigner T, Vornehm SI, Zeiler G, Dudhia J, von der Mark K, Bayliss MT. Suppression of cartilage matrix gene expression in upper zone chondrocytes of osteoarthritic cartilage. Arthritis Rheum 1997; 40: 562-569 (Pubitemid 27123673)
29. Vornehm SI, Dudhia J, von der Mark K, Aigner T. Expression of collagen types IX and XI and other major cartilage matrix components by human fetal chondrocytes in vivo. Matrix Biol 1996; 15: 91-98 (Pubitemid 26362358)
30. Aigner T, Dietz U, Stoss H, von der Mark K. Differential expression of collagen types I, II, III, and X in human osteophytes. Lab Invest 1995; 73: 236-243
31. Maroudas A. Physicochemical properties of articular cartilage. In: Freeman MAR (ed.), Adult articular cartilage, 2 ed. Tunbridge Wells: Pitman Medical Publishing; 1980: 215-290
32. Bank RA, Bayliss MT, Lafeber FPJG, Maroudas A, TeKoppele JM. Ageing and zonal variation in posttranslational modification of collagen in normal human articular cartilage. Biochem J 1998; 330: 345-351
33. Lafeber FPJG, van der Kraan PM, van Roy JLAM, van den Berg WB, Bijlsma JWJ. Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage. Am J Pathol 1992; 140: 1421-1429
34. Cancedda R, Descalzi-Cancedda F, Castagnola P. Chondrocyte differentiation. Int Rev Cytol 1995; 159: 265-358.
35. Benya PD, Padilla SR, Nimni ME. Independent regulation of collagen types by chondrocytes during the loss of differentiated function in culture. Cell 1978; 15: 1313-1321
36. Benya PD, Padilla SR, Nimni ME. The progeny of rabbit articular chondrocytes synthesize collagen types I and III and type I trimer, but not type II. Verifications by cyanogen bromide peptide analysis. Biochemistry 1977; 16-5: 865-872
37. von der Mark K, Gauss V, von der Mark H, Müller PK. Relationship between cell shape and type of collagen synthesized as chondrocytes lose their cartilage phenotype in culture. Nature 1977; 267: 531-532 (Pubitemid 8098481)
38. Roach HI, Yamada N, Cheung KSC, Tilley S, Clarke NMP. Abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes is associated with demethylation of specific CpGs in the promotor. Arthritis Rheum 2005; 52: 3110-3124 (Pubitemid 41447092)
39. Roach HI, Inglis S, Partridge KA, Clarke NMP, Richard OC. Can changes in the DNA methylation pattern explain the clonally inherited altered phenotypte of osteoarhritic chondrocytes? In: Landis W, Sodek J, Eds. Proceedings of the 8th International Conference on the Chemistry & Biology of Mineralized Tissues. Toronto: University of Toronto; 2005: pp. 192-195
40. Lindblad S, Hedfors E. Arthroscopic and immunohistologic characterization of knee joint synovitis in osteoarthritis. Arthritis Rheum 1987; 30-10: 1081-1088 (Pubitemid 18027294)
41. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002; 20: 633-640
42. Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis - results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis Cartilage 2005; 13: 361-367 (Pubitemid 40631281)
43. Fassbender HG. Inflammatory reactions in arthritis. In: Davies ME, Dingle JT (eds.), Immunopharmacology of joints and connective tissue. London: Academic Press; 1994: 165-198
44. Dettmer N, Barz B. Morphologische Veränderungen der synovialen Gelenkkapselanteile bei Arthrosis deformans. Archiv für orthopaedische und Unfallchirurgie 1977; 89: 61-79. (Pubitemid 8148277)
45. Hamerman D, Klagsbrunn M. Osteoarthritis - emerging evidence for cell interactions in the breakdown and remodeling of cartilage. Am J Med 1985; 78: 495-499 (Pubitemid 15107934)
46. Revell PA, Mayston V, Lalor P, Mapp P. The synovial membrane in OA: a histologic study including the characterisation of the cellular infiltrate present in inflammatory OA using monoclonal antibodies. Ann Rheum Dis 1988; 47: 300-307 (Pubitemid 18091643)
47. Myers SL, Flusser D, Brandt KD, Heck DA. Prevalence of cartilage shards in synovium and their association with synovitis in patients with early and endstage osteoarthritis. J Rheumatol 1992; 19: 1247-1251
48. Goldenberg DL, Egan MS, Cohen AS. Inflammatory synovitis in degenerative joint disease. J Rheumatol 1982; 9: 204-209 (Pubitemid 12014859)
49. Haraoui B, Pelletier JP, Cloutier J-M, Faure M-P, Martel-Pelletier J. Synovial membrane histology and immunopathology in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1991; 34-2: 153-163
50. Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 1997; 24: 365-371 (Pubitemid 27104104)
51. Firestein GS, Paine MM, Littman BH. Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium. Arthritis Rheum 1991; 34: 1094-1105
52. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH. In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 1991; 34: 1076-1084
53. Tyler JA. Articular cartilage cultured with catabolin (pig interleukin 1) synthesizes decreased number of normal proteoglycan molecules. Biochem J 1985; 227: 869-878
54. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002; 46: 2648-2657 (Pubitemid 36118928)
55. Lefebvre V, Peeters-Joris C, Vaes G. Modulation by interleukin 1 and tumor necrosis factor a of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1990; 1052: 366-378 (Pubitemid 20168844)
56. Pihlajaniemi T, Myllylä R, Kukkinen M, Prockop DJ. Partial characterization of a low molecular weight human collagen that undergoes alternative splicing. Proc Natl Acad Sci USA 1987; 84: 940-944 (Pubitemid 17031543)
57. Miossec P. Pro- and antiinflammatory cytokine balance in RA. Clin Exp Rheumatol 1995; 13: 13-16
58. Burr DB. The importance of subchondral bone in osteoarthrosis. Curr Opin Rheumatol 1998; 10: 256-262
59. Bergink AP, Uitterlinden AG, van Leeuwen JP, Hofman A, Verhaar JA, Pols HA. Bone mineral density and vertebral fracture history are associated with incident and progressive radiographic knee osteoarthritis in elderly men and women: The Rotterdam Study. Bone 2005; 37: 446-456 (Pubitemid 41317317)
60. Felson DT, Neogi T. Osteoarthritis: is it a disease of cartilage or of bone? Arthritis Rheum 2004; 50: 341-344
61. Kraus V, Feng S, Wang A, et al. Trabecular morphometry by fractal signal analysis, a novel progression marker of osteoarthritis. Arthritis Rheum 2009; 3711-3722
62. Amir G, Pirie CJ, Rashad S, Revell PA. Remodelling of subchondral bone in osteoarthritis: a histomorphometric study. J Clin Pathol 1992; 45: 990-992
63. Dieppe P. Subchondral bone should be the main target for the treatment of pain and disease progression in osteoarthritis. Osteoarthritis Cartilage 1999; 7: 325-326 (Pubitemid 29244113)
64. Felson DT, Chaisson CE, Hill CL, et al. The association of bone marrow lesions with pain in knee osteoarthritis. Ann Intern Med 2001; 134: 541-549 (Pubitemid 32245315)
65. Hayami T, Pickarski M, Wesolowski GA, et al. The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 2004; 50: 1193-1206 (Pubitemid 38480830)